Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy

Medical Oncology

Volumn 15, Issue 3, 1998, Pages 174-182

  Ten Bokkel Huinink, W W ^a   De Swart, C A M ^b   Van Toorn, D W ^c   Morack, G ^d   Breed, W P M ^e   Hillen, H F P ^e   Van Der Hoeven, J J M ^f   Reed, N S ^g   Fairlamb, D J ^h   Chan, S Y T ⁱ   Godfrey, K A ^j   Kristensen, G B ^k   Van Tinteren, H ^a   Ehmer, B ^l  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b Infection and Immunology   (Netherlands)

^c Ziekenhuis Centrum   (Netherlands)

^d St Joseph Krankenhauses Berlin Tempelhof   (Germany)

^e CATHARINA HOSPITAL   (Netherlands)

^f AMSTELLAND HOSPITAL   (Netherlands)

^g BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^h ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

ⁱ Department of Urology   (United Kingdom)

^j SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^k OSLO UNIVERSITY HOSPITAL   (Norway)

^l F HOFFMANN LA ROCHE LTD   (Switzerland)

more..

Author keywords

Cancer; Carboplatin; Cisplatin; Erythropoiesis; Myelosuppression

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MULTICENTER STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; VERTIGO;

EID: 0031766238     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02821936     Document Type: Article

References (21)

1. Abels R. Erythropoietin for anaemia in cancer patients. Eur J Cancer 1993; 29A: 2-8.
2. Kaye SB et al. Randomized study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer. Lancet 1992; 340: 329-333.
3. Ludwig H et al. Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors. Ann Oncol 1993; 4: 161-167.
4. Bush RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 1986; 12: 2047-2050.
5. Girinski T et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989; 16: 37-42.
6. Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrent rate [letter]. Lancet 1982; ii: 662.
7. Foster RS Jr, Costanza MC, Foster JC, Wanner MC, Foster CB. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 1985; 55: 1195-1201.
8. Balfour HH Jr. Transfusion and the human immunodeficiency virus. Transfusion 1993; 33: 101-102.
9. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-1376.
10. Heiss MM et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-1867.
11. Wu HS, Little AG. Perioperative blood transfusions and cancer recurrence. J Clin Oncol 1988; 6: 1348-1354.
12. Miller CB et al. A phase I/II trial of erythropoietin in the treatment of cisplatin-associated anemia. J Natl Cancer Inst 1992; 84: 98-103.
13. Ludwig H et al. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990; 322: 1693-1699.
14. Cazzola M et al. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response. Blood 1995; 86: 4446-4453.
15. Platanias LC et al. Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients. J Clin Oncol 1991; 9: 2021-2026.
16. de Campos E et al. Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer. J Clin Oncol 1995; 13: 1623-1631.
17. Berdel WE, Oberberg D, Reufi B, Thiel E. Studies on the role of recombinant human erythropoietin in the growth regulation of human nonhematopoietic tumor cells in vitro. Ann Hematol 1991; 63: 5-8.
18. Neijt JP. Advanced ovarian cancer. Consultant series: The role of haematopoietic growth factors No. 4. Gardiner-Caldwell Communications: 1990.
19. Gershenson DM et al. Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin-based chemotherapy. Obstet Gynecol 1989; 73: 798-802.
20. Markman M et al. The use of recombinant human erythropoietin to prevent carboplatin-induced anemia. Gynecol Oncol 1993; 49: 172-176.
21. Beguin Y, Yerna M, Loo M, Weber M, Fillet G. Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. Br J Haematol 1992; 82: 648-653.